Jan 6, 2016
|
Ardelyx Announces Proposed Public Offering of Common Stock
|
Jan 5, 2016
|
Ardelyx Reports Positive Clinical Results of RDX022 for the Treatment of Hyperkalemia
|
Jan 4, 2016
|
Ardelyx Strengthens Executive Leadership Team with the Appointment of Paul Korner, MD, MBA, as Executive Vice President and Chief Medical Officer
|
Nov 12, 2015
|
Ardelyx Reports Third Quarter 2015 Financial Results
|
Oct 29, 2015
|
Ardelyx to Report Third Quarter 2015 Financial Results on November 12, 2015
|
Oct 28, 2015
|
Ardelyx Announces Upcoming Presentations for Tenapanor at the American Society of Nephrology's Kidney Week Meeting 2015
|
Oct 26, 2015
|
Ardelyx Appoints William Bertrand, Jr. to Its Board of Directors
|
Oct 8, 2015
|
Ardelyx to Present Phase 2 Data for Tenapanor in IBS-C Patients at the 2015 American College of Gastroenterology Annual Meeting
|
Sep 1, 2015
|
Ardelyx Regains NaP2b Program from Sanofi
|
Aug 12, 2015
|
Ardelyx Reports Second Quarter 2015 Financial Results
|